Cancer patients on Doxorubicin and Cyclophosphamide treatment were proven to have elevated levels of free radicals leading to overproduction of inflammatory mediators as Interleukin-1β (IL-1β) and tumor necrosis factor-alpha (TNF-α) (Salas-Ramirez et al. 2015). This evidence concerns the gene TNF and cancer.